Skip to content

Clinical trials

Phase 2 Carcinoma, Hepatocellular trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Country / region: Spain Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20082
20092
20112
20122
20132
20151
20171
20181
20191
20201
20215
20221
20236
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting5
Recruiting3
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Clinica Universidad de Navarra, Universidad de Navarra4
AbbVie1
Astellas Pharma Inc1
AstraZeneca1
BeiGene1
Boston Scientific Corporation1
Bristol-Myers Squibb1
CatalYm GmbH1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular30
Liver Neoplasms4
Cholangiocarcinoma3
Ovarian Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Melanoma2
Neoplasms2
Squamous Cell Carcinoma of Head and Neck2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.